Nebicina Flaconcino (Tobramycin)

Tobramycin, the active ingredient in Nebicina Flaconcino, is an aminoglycoside antibiotic presented as an injectable solution for intramuscular and intravenous use. It treats severe infections caused by susceptible Gram‑negative bacteria, including Pseudomonas aeruginosa, and is employed in complicated urinary and respiratory tract infections.

GNH USA supplies Nebicina Flaconcino as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, and pharmacies worldwide. We adhere to stringent quality standards and provide comprehensive technical support.

Nebicina Flaconcino (tobramycin) is used to treat infections caused by Gram‑negative bacteria, particularly in serious systemic disease. - Severe Gram‑negative bacterial infections: achieves bacterial eradication in life‑threatening conditions. - Pseudomonas aeruginosa infections: provides effective coverage against this resistant pathogen. - Complicated urinary tract infections: clears infection when oral agents are insufficient. - Respiratory tract infections: treats severe lower respiratory infections caused by susceptible organisms.

Tobramycin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nephrotoxicity: reversible increase in serum creatinine or reduced urine output. - Ototoxicity: transient hearing changes or tinnitus. - Injection site reactions: pain, erythema, or swelling at the administration site. - Fever: mild temperature elevation. - Rash: mild skin eruption.

Serious or Rare Side Effects: -